;PMID: 3259740
;source_file_647.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..47] = [t:0..47]
;1)sentence:[e:53..185] = [t:53..185]
;2)section:[e:189..223] = [t:189..223]
;3)section:[e:227..317] = [t:227..317]
;4)sentence:[e:321..580] = [t:321..580]
;5)sentence:[e:581..758] = [t:581..758]
;6)sentence:[e:759..945] = [t:759..945]
;7)sentence:[e:947..1094] = [t:947..1094]
;8)sentence:[e:1095..1410] = [t:1095..1410]
;9)sentence:[e:1411..1526] = [t:1411..1526]
;10)sentence:[e:1527..1681] = [t:1527..1681]
;11)sentence:[e:1682..1887] = [t:1682..1887]
;12)sentence:[e:1888..2071] = [t:1888..2071]
;13)sentence:[e:2072..2200] = [t:2072..2200]
;14)section:[e:2204..2248] = [t:2204..2248]
;Token/POS Errors
;ERROR_POS mismatch [39..40] t:token e:CD 1

;section 0 Span:0..47
;Toxicol Appl Pharmacol. 1988 Jun 15;94(1):1-10.
(SEC
  (FRAG (NNP:[0..7] Toxicol) (NNP:[8..12] Appl) (NNP:[13..22] Pharmacol)
        (.:[22..23] .) (CD:[24..28] 1988) (JJ:[29..32] Jun) (CD:[33..38] 15;94)
        (NN:[38..39] -LRB-) (token:[39..40] 1) (-RRB-:[40..41] -RRB-)
        (::[41..42] :) (CD:[42..46] 1-10) (.:[46..47] .)))

;sentence 1 Span:53..185
;The effect of piperonyl butoxide on hepatic cytochrome P-450-dependent 
;monooxygenase activities in rainbow trout (Salmo gairdneri).
;[67..85]:substance:"piperonyl butoxide"
;[97..113]:cyp450:"cytochrome P-450"
;[125..138]:substance:"monooxygenase"
(SENT
  (NP-HLN
    (NP (DT:[53..56] The) (NN:[57..63] effect))
    (PP (IN:[64..66] of)
      (NP (NN:[67..76] piperonyl) (NN:[77..85] butoxide)))
    (PP (IN:[86..88] on)
      (NP (JJ:[89..96] hepatic)
        (ADJP
          (NML (NN:[97..107] cytochrome) (NN:[108..113] P-450))
          (HYPH:[113..114] -) (JJ:[114..123] dependent))
        (NN:[125..138] monooxygenase) (NNS:[139..149] activities)))
    (PP-LOC (IN:[150..152] in)
      (NP
        (NP (JJ:[153..160] rainbow) (NNS:[161..166] trout))
        (NP (-LRB-:[167..168] -LRB-) (NNP:[168..173] Salmo)
            (NNP:[174..183] gairdneri) (-RRB-:[183..184] -RRB-))))
    (.:[184..185] .)))

;section 2 Span:189..223
;Erickson DA, Goodrich MS, Lech JJ.
(SEC
  (FRAG (NNP:[189..197] Erickson) (NNP:[198..200] DA) (,:[200..201] ,)
        (NNP:[202..210] Goodrich) (NNP:[211..213] MS) (,:[213..214] ,)
        (NNP:[215..219] Lech) (NNP:[220..223] JJ.)))

;section 3 Span:227..317
;Department of Pharmacology and Toxicology, Medical College of Wisconsin, 
;Milwaukee 53226.
(SEC
  (FRAG (NNP:[227..237] Department) (IN:[238..240] of)
        (NNP:[241..253] Pharmacology) (CC:[254..257] and)
        (NNP:[258..268] Toxicology) (NNP:[268..269] ,) (NNP:[270..277] Medical)
        (NNP:[278..285] College) (IN:[286..288] of) (NNP:[289..298] Wisconsin)
        (,:[298..299] ,) (NNP:[301..310] Milwaukee) (.:[311..316] 53226)
        (.:[316..317] .)))

;sentence 4 Span:321..580
;Although piperonyl butoxide (PBO) is commonly used both in vivo and in vitro
;as  an inhibitor of cytochrome P-450-dependent monooxygenase (MO) activity in
;a wide  variety of species, the effect of PBO on the hepatic MO of fishes has
;never been  characterized.
;[330..348]:substance:"piperonyl butoxide"
;[350..353]:substance:"PBO"
;[405..414]:substance:"inhibitor"
;[418..434]:cyp450:"cytochrome P-450"
;[445..458]:substance:"monooxygenase"
;[460..462]:substance:"MO"
;[518..521]:substance:"PBO"
;[537..539]:substance:"MO"
(SENT
  (S
    (SBAR-ADV (IN:[321..329] Although)
      (S
        (NP-SBJ-2
          (NP (NN:[330..339] piperonyl) (NN:[340..348] butoxide))
          (NP (-LRB-:[349..350] -LRB-) (NN:[350..353] PBO)
              (-RRB-:[353..354] -RRB-)))
        (VP (VBZ:[355..357] is)
          (VP
            (ADVP (RB:[358..366] commonly))
            (VBN:[367..371] used)
            (NP-2 (-NONE-:[371..371] *))
            (ADVP (CC:[372..376] both)
              (ADVP (FW:[377..379] in) (FW:[380..384] vivo))
              (CC:[385..388] and)
              (ADVP (FW:[389..391] in) (FW:[392..397] vitro)))
            (PP (IN:[398..400] as)
              (NP
                (NP (DT:[402..404] an) (NN:[405..414] inhibitor))
                (PP (IN:[415..417] of)
                  (NP
                    (ADJP
                      (NML (NN:[418..428] cytochrome) (NN:[429..434] P-450))
                      (HYPH:[434..435] -) (JJ:[435..444] dependent))
                    (NML
                      (NML (NN:[445..458] monooxygenase))
                      (NML (-LRB-:[459..460] -LRB-) (NN:[460..462] MO)
                           (-RRB-:[462..463] -RRB-)))
                    (NN:[464..472] activity)))))
            (PP (IN:[473..475] in)
              (NP
                (NP (DT:[476..477] a) (JJ:[478..482] wide)
                    (NN:[484..491] variety))
                (PP (IN:[492..494] of)
                  (NP (NNS:[495..502] species)))))))))
    (,:[502..503] ,)
    (NP-SBJ-1
      (NP (DT:[504..507] the) (NN:[508..514] effect))
      (PP (IN:[515..517] of)
        (NP (NN:[518..521] PBO)))
      (PP (IN:[522..524] on)
        (NP
          (NP (DT:[525..528] the) (JJ:[529..536] hepatic) (NN:[537..539] MO))
          (PP (IN:[540..542] of)
            (NP (NNS:[543..549] fishes))))))
    (VP (VBZ:[550..553] has)
      (ADVP-TMP (RB:[554..559] never))
      (VP (VBN:[560..564] been)
        (VP (VBN:[566..579] characterized)
          (NP-1 (-NONE-:[579..579] *)))))
    (.:[579..580] .)))

;sentence 5 Span:581..758
;The MO activity in hepatic microsomes from rainbow trout exposed  to either 1
;or 2 ppm PBO for 24 hr in a static system was induced to a similar  level in
;both treatment groups.
;[585..587]:substance:"MO"
;[657..658]:quantitative-value:"1"
;[662..663]:quantitative-value:"2"
;[664..667]:quantitative-units:"ppm"
;[668..671]:substance:"PBO"
;[676..678]:quantitative-value:"24"
;[679..681]:quantitative-units:"hr"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[581..584] The) (NN:[585..587] MO) (NN:[588..596] activity))
      (PP-LOC (IN:[597..599] in)
        (NP
          (NP (JJ:[600..607] hepatic) (NNS:[608..618] microsomes))
          (PP (IN:[619..623] from)
            (NP
              (NP (JJ:[624..631] rainbow) (NNS:[632..637] trout))
              (VP (VBN:[638..645] exposed)
                (NP (-NONE-:[645..645] *))
                (PP-CLR (TO:[647..649] to)
                  (NP
                    (NML
                      (QP (CC:[650..656] either) (CD:[657..658] 1)
                          (CC:[659..661] or) (CD:[662..663] 2))
                      (NN:[664..667] ppm))
                    (NN:[668..671] PBO)))
                (PP-TMP (IN:[672..675] for)
                  (NP (CD:[676..678] 24) (NN:[679..681] hr)))
                (PP-LOC (IN:[682..684] in)
                  (NP (DT:[685..686] a) (JJ:[687..693] static)
                      (NN:[694..700] system)))))))))
    (VP (VBD:[701..704] was)
      (VP (VBN:[705..712] induced)
        (NP-1 (-NONE-:[712..712] *))
        (PP (TO:[713..715] to)
          (NP (DT:[716..717] a) (JJ:[718..725] similar) (NN:[727..732] level)))
        (PP-LOC (IN:[733..735] in)
          (NP (DT:[736..740] both) (NN:[741..750] treatment)
              (NNS:[751..757] groups)))))
    (.:[757..758] .)))

;sentence 6 Span:759..945
;Conversely, when PBO was administered in a  flow-through system to trout, the
;hepatic microsomes of treated animals  contained MO activities that were
;induced in a dose-dependent manner.
;[776..779]:substance:"PBO"
;[886..888]:substance:"MO"
(SENT
  (S
    (ADVP (RB:[759..769] Conversely))
    (,:[769..770] ,)
    (SBAR-ADV
      (WHADVP (WRB:[771..775] when))
      (S
        (NP-SBJ-2 (NN:[776..779] PBO))
        (VP (VBD:[780..783] was)
          (VP (VBN:[784..796] administered)
            (NP-2 (-NONE-:[796..796] *))
            (PP (IN:[797..799] in)
              (NP (DT:[800..801] a) (NN:[803..815] flow-through)
                  (NN:[816..822] system)))
            (PP-CLR (TO:[823..825] to)
              (NP (NNS:[826..831] trout)))))))
    (,:[831..832] ,)
    (NP-SBJ
      (NP (DT:[833..836] the) (JJ:[837..844] hepatic)
          (NNS:[845..855] microsomes))
      (PP (IN:[856..858] of)
        (NP (JJ:[859..866] treated) (NNS:[867..874] animals))))
    (VP (VBD:[876..885] contained)
      (NP
        (NP (NN:[886..888] MO) (NNS:[889..899] activities))
        (SBAR
          (WHNP-1 (WDT:[900..904] that))
          (S
            (NP-SBJ-1 (-NONE-:[904..904] *T*))
            (VP (VBD:[905..909] were)
              (VP (VBN:[910..917] induced)
                (NP-1 (-NONE-:[917..917] *))
                (PP-MNR (IN:[918..920] in)
                  (NP (DT:[921..922] a)
                    (ADJP (NN:[923..927] dose) (HYPH:[927..928] -)
                          (JJ:[928..937] dependent))
                    (NN:[938..944] manner)))))))))
    (.:[944..945] .)))

;sentence 7 Span:947..1094
;Furthermore, total cytochrome P-450 was significantly increased in the livers
;of  trout treated in a flow-through system with 1 ppm or more of PBO.
;[966..982]:cyp450:"cytochrome P-450"
;[1073..1074]:quantitative-value:"1"
;[1075..1078]:quantitative-units:"ppm"
;[1090..1093]:substance:"PBO"
(SENT
  (S
    (ADVP (RB:[947..958] Furthermore))
    (,:[958..959] ,)
    (NP-SBJ-1 (JJ:[960..965] total)
       (NN:[966..976] cytochrome) (NN:[977..982] P-450))
    (VP (VBD:[983..986] was)
      (VP
        (ADVP (RB:[987..1000] significantly))
        (VBN:[1001..1010] increased)
        (NP-1 (-NONE-:[1010..1010] *))
        (PP-LOC (IN:[1011..1013] in)
          (NP
            (NP (DT:[1014..1017] the) (NNS:[1018..1024] livers))
            (PP (IN:[1025..1027] of)
              (NP
                (NP (NNS:[1029..1034] trout))
                (VP (VBN:[1035..1042] treated)
                  (NP (-NONE-:[1042..1042] *))
                  (PP (IN:[1043..1045] in)
                    (NP (DT:[1046..1047] a) (NN:[1048..1060] flow-through)
                        (NN:[1061..1067] system)))
                  (PP-CLR (IN:[1068..1072] with)
                    (NP
                      (NP
                        (NP (CD:[1073..1074] 1) (NN:[1075..1078] ppm))
                        (QP (CC:[1079..1081] or) (JJR:[1082..1086] more)))
                      (PP (IN:[1087..1089] of)
                        (NP (NN:[1090..1093] PBO))))))))))))
    (.:[1093..1094] .)))

;sentence 8 Span:1095..1410
;The in vitro  inhibition kinetics of PBO toward the
;7-ethoxycoumarin-O-deethylase (ECOD) and  7-ethoxyresorufin-O-deethylase
;(EROD) activities of hepatic microsomes from  trout treated with
;beta-naphthoflavone (BNF) (100 mg/kg, ip) or PBO (4 ppm by  flow-through) and
;untreated trout were compared with Dixon plots.
;[1132..1135]:substance:"PBO"
;[1147..1176]:substance:"7-ethoxycoumarin-O-deethylase"
;[1178..1182]:substance:"ECOD"
;[1189..1219]:substance:"7-ethoxyresorufin-O-deethylase"
;[1221..1225]:substance:"EROD"
;[1285..1304]:substance:"beta-naphthoflavone"
;[1306..1309]:substance:"BNF"
;[1312..1315]:quantitative-value:"100"
;[1316..1321]:quantitative-units:"mg/kg"
;[1330..1333]:substance:"PBO"
;[1335..1336]:quantitative-value:"4"
;[1337..1340]:quantitative-units:"ppm"
(SENT
  (S
    (NP-SBJ-2
      (NP (DT:[1095..1098] The)
        (ADJP (FW:[1099..1101] in) (FW:[1102..1107] vitro))
        (NN:[1109..1119] inhibition) (NNS:[1120..1128] kinetics))
      (PP (IN:[1129..1131] of)
        (NP (NN:[1132..1135] PBO)))
      (PP (IN:[1136..1142] toward)
        (NP
          (NP (DT:[1143..1146] the)
            (NML
              (NML
                (NML
                  (NML (NN:[1147..1176] 7-ethoxycoumarin-O-deethylase))
                  (NML (-LRB-:[1177..1178] -LRB-) (NN:[1178..1182] ECOD)
                       (-RRB-:[1182..1183] -RRB-)))
                (NML-1 (-NONE-:[1183..1183] *P*)))
              (CC:[1184..1187] and)
              (NML
                (NML
                  (NML (NN:[1189..1219] 7-ethoxyresorufin-O-deethylase))
                  (NML (-LRB-:[1220..1221] -LRB-) (NN:[1221..1225] EROD)
                       (-RRB-:[1225..1226] -RRB-)))
                (NML-1 (NNS:[1227..1237] activities)))))
          (PP (IN:[1238..1240] of)
            (NP
              (NP (JJ:[1241..1248] hepatic) (NNS:[1249..1259] microsomes))
              (PP (IN:[1260..1264] from)
                (NP
                  (NP
                    (NP (NNS:[1266..1271] trout))
                    (VP (VBN:[1272..1279] treated)
                      (NP (-NONE-:[1279..1279] *))
                      (PP-CLR (IN:[1280..1284] with)
                        (NP
                          (NP
                            (NP (NN:[1285..1304] beta-naphthoflavone))
                            (NP (-LRB-:[1305..1306] -LRB-) (NN:[1306..1309] BNF)
                                (-RRB-:[1309..1310] -RRB-))
                            (PRN (-LRB-:[1311..1312] -LRB-)
                              (NP
                                (NP (CD:[1312..1315] 100) (NN:[1316..1318] mg))
                                (PP (SYM:[1318..1319] /)
                                  (NP (NN:[1319..1321] kg))))
                              (,:[1321..1322] ,)
                              (NP-ADV (NN:[1323..1325] ip))
                              (-RRB-:[1325..1326] -RRB-)))
                          (CC:[1327..1329] or)
                          (NP (NN:[1330..1333] PBO)
                            (PRN (-LRB-:[1334..1335] -LRB-)
                              (FRAG
                                (NP (CD:[1335..1336] 4) (NN:[1337..1340] ppm))
                                (PP (IN:[1341..1343] by)
                                  (NP (NN:[1345..1357] flow-through))))
                              (-RRB-:[1357..1358] -RRB-)))))))
                  (CC:[1359..1362] and)
                  (NP (JJ:[1363..1372] untreated) (NNS:[1373..1378] trout)))))))))
    (VP (VBD:[1379..1383] were)
      (VP (VBN:[1384..1392] compared)
        (NP-2 (-NONE-:[1392..1392] *))
        (PP-MNR (IN:[1393..1397] with)
          (NP (NNP:[1398..1403] Dixon) (NNS:[1404..1409] plots)))))
    (.:[1409..1410] .)))

;sentence 9 Span:1411..1526
;With respect  to ECOD activity, the slopes of Dixon plots from control, BNF-
;and PBO-treated  animals were similar.
;[1428..1432]:substance:"ECOD"
;[1483..1486]:substance:"BNF"
;[1492..1495]:substance:"PBO"
(SENT
  (S
    (PP (IN:[1411..1415] With)
      (NP
        (NP (NN:[1416..1423] respect))
        (PP (TO:[1425..1427] to)
          (NP (NN:[1428..1432] ECOD) (NN:[1433..1441] activity)))))
    (,:[1441..1442] ,)
    (NP-SBJ
      (NP (DT:[1443..1446] the) (NNS:[1447..1453] slopes))
      (PP (IN:[1454..1456] of)
        (NP
          (NP (NNP:[1457..1462] Dixon) (NNS:[1463..1468] plots))
          (PP (IN:[1469..1473] from)
            (NP
              (NP (NN:[1474..1481] control)
                (NML-2 (-NONE-:[1481..1481] *P*)))
              (,:[1481..1482] ,)
              (NP
                (ADJP (NN:[1483..1486] BNF) (HYPH:[1486..1487] -)
                  (ADJP-1 (-NONE-:[1487..1487] *P*)))
                (NML-2 (-NONE-:[1487..1487] *P*)))
              (CC:[1488..1491] and)
              (NP
                (ADJP (NN:[1492..1495] PBO) (HYPH:[1495..1496] -)
                  (ADJP-1 (VBN:[1496..1503] treated)))
                (NML-2 (NNS:[1505..1512] animals))))))))
    (VP (VBD:[1513..1517] were)
      (ADJP-PRD (JJ:[1518..1525] similar)))
    (.:[1525..1526] .)))

;sentence 10 Span:1527..1681
;However, the slopes of Dixon plots of EROD inhibition by  PBO in microsomes
;from BNF- and PBO-treated trout were significantly different  from each
;other.
;[1565..1569]:substance:"EROD"
;[1585..1588]:substance:"PBO"
;[1608..1611]:substance:"BNF"
;[1617..1620]:substance:"PBO"
(SENT
  (S
    (ADVP (RB:[1527..1534] However))
    (,:[1534..1535] ,)
    (NP-SBJ
      (NP (DT:[1536..1539] the) (NNS:[1540..1546] slopes))
      (PP (IN:[1547..1549] of)
        (NP
          (NP (NNP:[1550..1555] Dixon) (NNS:[1556..1561] plots))
          (PP (IN:[1562..1564] of)
            (NP
              (NP (NN:[1565..1569] EROD) (NN:[1570..1580] inhibition))
              (PP (IN:[1581..1583] by)
                (NP (NN:[1585..1588] PBO)))
              (PP-LOC (IN:[1589..1591] in)
                (NP
                  (NP (NNS:[1592..1602] microsomes))
                  (PP (IN:[1603..1607] from)
                    (NP
                      (NP
                        (ADJP (NN:[1608..1611] BNF) (HYPH:[1611..1612] -)
                          (ADJP-1 (-NONE-:[1612..1612] *P*)))
                        (NML-2 (-NONE-:[1612..1612] *P*)))
                      (CC:[1613..1616] and)
                      (NP
                        (ADJP (NN:[1617..1620] PBO) (HYPH:[1620..1621] -)
                          (ADJP-1 (VBN:[1621..1628] treated)))
                        (NML-2 (NNS:[1629..1634] trout))))))))))))
    (VP (VBD:[1635..1639] were)
      (ADJP-PRD (RB:[1640..1653] significantly) (JJ:[1654..1663] different)
        (PP (IN:[1665..1669] from)
          (NP (DT:[1670..1674] each) (JJ:[1675..1680] other)))))
    (.:[1680..1681] .)))

;sentence 11 Span:1682..1887
;Treatment of trout with PBO in a flow-through system resulted  in an increase
;in ECOD and EROD activity in hepatic microsomes while  simultaneously
;decreasing their activity toward [14C]rotenone oxidation.
;[1706..1709]:substance:"PBO"
;[1763..1767]:substance:"ECOD"
;[1772..1776]:substance:"EROD"
;[1863..1876]:substance:"[14C]rotenone"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1682..1691] Treatment))
      (PP (IN:[1692..1694] of)
        (NP (NNS:[1695..1700] trout)))
      (PP (IN:[1701..1705] with)
        (NP (NN:[1706..1709] PBO)))
      (PP-LOC (IN:[1710..1712] in)
        (NP (DT:[1713..1714] a) (NN:[1715..1727] flow-through)
            (NN:[1728..1734] system))))
    (VP (VBD:[1735..1743] resulted)
      (PP-CLR (IN:[1745..1747] in)
        (NP
          (NP (DT:[1748..1750] an) (NN:[1751..1759] increase))
          (PP (IN:[1760..1762] in)
            (NP
              (NP (NN:[1763..1767] ECOD)
                (NML-1 (-NONE-:[1767..1767] *P*)))
              (CC:[1768..1771] and)
              (NP (NN:[1772..1776] EROD)
                (NML-1 (NN:[1777..1785] activity)))))
          (PP-LOC (IN:[1786..1788] in)
            (NP (JJ:[1789..1796] hepatic) (NNS:[1797..1807] microsomes)))))
      (SBAR-ADV (IN:[1808..1813] while)
        (S
          (NP-SBJ (-NONE-:[1813..1813] *))
          (ADVP (RB:[1815..1829] simultaneously))
          (VP (VBG:[1830..1840] decreasing)
            (NP
              (NP (PRP$:[1841..1846] their) (NN:[1847..1855] activity))
              (PP (IN:[1856..1862] toward)
                (NP (NN:[1863..1876] -LSB-14C-RSB-rotenone)
                    (NN:[1877..1886] oxidation))))))))
    (.:[1886..1887] .)))

;sentence 12 Span:1888..2071
;These  data suggest that the cytochrome P-450 isozyme composition in hepatic
;microsomes  from PBO-treated rainbow trout may be qualitatively different
;from that of  BNF-treated trout.
;[1917..1941]:cyp450:"cytochrome P-450 isozyme"
;[1982..1985]:substance:"PBO"
;[2053..2056]:substance:"BNF"
(SENT
  (S
    (NP-SBJ (DT:[1888..1893] These) (NNS:[1895..1899] data))
    (VP (VBP:[1900..1907] suggest)
      (SBAR (IN:[1908..1912] that)
        (S
          (NP-SBJ
            (NP (DT:[1913..1916] the)
              
              (NML (NN:[1917..1927] cytochrome) (NN:[1928..1933] P-450))
              (NN:[1934..1941] isozyme)
              (NN:[1942..1953] composition))
            (PP-LOC (IN:[1954..1956] in)
              (NP
                (NP (JJ:[1957..1964] hepatic) (NNS:[1965..1975] microsomes))
                (PP (IN:[1977..1981] from)
                  (NP
                    (ADJP (NN:[1982..1985] PBO) (HYPH:[1985..1986] -)
                          (VBN:[1986..1993] treated))
                    (JJ:[1994..2001] rainbow) (NNS:[2002..2007] trout))))))
          (VP (MD:[2008..2011] may)
            (VP (VB:[2012..2014] be)
              (ADJP-PRD (RB:[2015..2028] qualitatively)
                        (JJ:[2029..2038] different)
                (PP (IN:[2039..2043] from)
                  (NP
                    (NP (DT:[2044..2048] that))
                    (PP (IN:[2049..2051] of)
                      (NP
                        (ADJP (NN:[2053..2056] BNF) (HYPH:[2056..2057] -)
                              (VBN:[2057..2064] treated))
                        (NNS:[2065..2070] trout)))))))))))
    (.:[2070..2071] .)))

;sentence 13 Span:2072..2200
;Also, the activity of hepatic microsomes from PBO-treated  trout toward a
;specific substrate may be either inhibited or induced.
;[2118..2121]:substance:"PBO"
;[2155..2164]:substance:"substrate"
(SENT
  (S
    (ADVP (RB:[2072..2076] Also))
    (,:[2076..2077] ,)
    (NP-SBJ-1
      (NP (DT:[2078..2081] the) (NN:[2082..2090] activity))
      (PP (IN:[2091..2093] of)
        (NP
          (NP (JJ:[2094..2101] hepatic) (NNS:[2102..2112] microsomes))
          (PP (IN:[2113..2117] from)
            (NP
              (NP
                (ADJP (NN:[2118..2121] PBO) (HYPH:[2121..2122] -)
                      (VBN:[2122..2129] treated))
                (NNS:[2131..2136] trout))
              (PP (IN:[2137..2143] toward)
                (NP (DT:[2144..2145] a) (JJ:[2146..2154] specific)
                    (NN:[2155..2164] substrate))))))))
    (VP (MD:[2165..2168] may)
      (VP (VB:[2169..2171] be)
        (VP (CC:[2172..2178] either) (VBN:[2179..2188] inhibited)
            (CC:[2189..2191] or) (VBN:[2192..2199] induced)
          (NP-1 (-NONE-:[2199..2199] *)))))
    (.:[2199..2200] .)))

;section 14 Span:2204..2248
;PMID: 3259740 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2204..2208] PMID) (::[2208..2209] :) (CD:[2210..2217] 3259740)
        (NN:[2218..2219] -LSB-) (NNP:[2219..2225] PubMed) (::[2226..2227] -)
        (NN:[2228..2235] indexed) (IN:[2236..2239] for)
        (NNP:[2240..2248] MEDLINE-RSB-)))
